AAIC 2025 Abstract
Aβ positive, tau biomarker negative cognitive impairment is associated with significant non‐Alzheimer's disease neuropathologies
By Konstantinos Ioannou, Richard J. Perrin, Khadidzha Abdullaieva, Show 5 more authorsKonstantinos Chiotis
Study in peopleBiomarkers
Abstract
Background: This study leverages biomarker and autopsy data with the aim to evaluate the impact of mixed pathologies on interpreting cognitive impairment within the Αβ and tau (AT) biomarker system.
